Skip to main content

Table 3 The proportion of patients who were dispensed benzodiazepines, z-hypnotics, and gabapentinoids, respectively

From: Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017

Year

2013

2014

2015

2016

2017

Benzodiazepines or z-hypnotics

No.

%a

No.

%a

No.

%a

No.

%a

No.

%a

 Oxazepam

2094

28

2091

27

2124

27

2183

28

2229

29

 Diazepam

1216

16

1251

16

1222

16

1272

17

1289

17

 Zopiclone

1026

14

964

12

932

12

936

12

863

11

 Nitrazepam

757

10

759

10

747

10

737

10

701

9

 Clonazepam

479

6

432

6

362

5

331

4

268

4

 Zolpidem

351

5

359

5

333

4

315

4

327

4

 Alprazolam

305

4

304

4

237

3

206

3

196

3

 Flunitrazepam

41

1

38

0

37

0

32

0

36

0

Gabapentinoids

No.

%a

No.

%a

No.

%a

No.

%a

No.

%a

 Pregabalin

487

6

449

6

491

6

523

7

591

8

 Gabapentin

260

3

240

3

277

4

291

4

310

4

  1. No. Number of patients, OAT Opioid agonist therapy
  2. aPercent of all patients who were dispensed an OAT opioid
  3. The table displays the proportion of all OAT patients who were dispensed different benzodiazepines, z-hypnotics, and gabapentinoids